EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Potential of the NRF2 Transcription Factor in Canine Mammary Neoplasms

Vitor de Moraes Pina de Carvalho iD, Anna Hielm-Björkman iD, Karine Araújo Damasceno, Thanielle Novaes Fontes, Carlos Humberto da Costa Vieira-Filho, Simone Nunes, Diego Carlos Dos Reis iD, Robin Moore iD, Stella Maria Barrouin-Melo iD, Geovanni Dantas Cassali iD, Alessandra Estrela-Lima iD

Cancers · 29.03.2026 · 18 (7) · 1107

DOI: 10.3390/cancers18071107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 29.03.2026. Verfasst von Vitor de Moraes Pina de Carvalho und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Center on Mammary Oncology (NPqOM/HOSPMEV), Federal University of Bahia, Salvador 40170-110, Bahia, Brazil. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado da Bahia, Fundação de Amparo à Pesquisa do Estado de Minas Gerais, National Council for Scientific and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Research based on the similarities between canine and human mammary tumors should extend beyond clinical, pathophysiological, epidemiological, and histopathological characteristics to include applicable molecular markers with prognostic significance. However, despite shared similarities, important differences must also be considered in comparative and translational studies. The nuclear erythroid 2-related factor (NRF2), a nuclear transcription factor that regulates the expression of antioxidant proteins, is pathologically activated during carcinogenesis. The role of NRF2 in human breast cancer is well established, making it a potential prognostic marker.

Objectives

This study aimed to evaluate NRF2 tissue expression in mammary neoplasms of female dogs and its association with tumor progression, other prognostic factors, and survival.

Methods

A group of 57 female dogs was studied. Tissue samples of mammary glands from 10 healthy dogs and 47 dogs with mammary neoplasms (39 malignant tumors and 8 benign tumors) were examined for NRF2 immunoexpression. Clinicopathological data and immunohistochemical expression, assessed by histochemical score (H-score), were correlated.

Results

NRF2 tissue expression showed a predominantly cytoplasmic distribution and a lower H-score in tumors with higher malignancy grading. Dogs with higher NRF2 H-scores had improved survival rates (p = 0.0036). Univariate analysis revealed significant associations between H-scores < 135 and behavior (p = 0.007), tumor size (p = 0.001), and Ki-67 index (p = 0.018).

Conclusions

These results suggest that NRF2 also holds prognostic value in the evaluation of canine mammary tumors.

Schlagwörter

Stichwörter der Autor:innen

H-scorebiomarkerbreast cancerdogoxidative stresstranscription factor

Autor:innen und Institutionen

  • Research Center on Mammary Oncology (NPqOM/HOSPMEV), Federal University of Bahia, Salvador 40170-110, Bahia, Brazil.
  • DogRisk Research Group, Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, 00790 Helsinki, Finland.
  • Laboratory for Global Health Research and Neglected Diseases, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador 40296-710, Bahia, Brazil.
  • Division of Molecular Pathology, The Institute of Cancer Research, London SM2 5NG, UK.
  • Department of Anatomy, Pathology, and Veterinary Clinics, Federal University of Bahia, Salvador 40170-110, Bahia, Brazil.
  • Laboratory of Comparative Pathology, Department of General Pathology, Federal University of Minas Gerais, Belo Horizonte 31270-901, Minas Gerais, Brazil.

ORCID-Profile: Vitor de Moraes Pina de Carvalho, Anna Hielm-Björkman, Diego Carlos Dos Reis, Robin Moore, Stella Maria Barrouin-Melo, Geovanni Dantas Cassali, Alessandra Estrela-Lima

Förderung

  • Fundação de Amparo à Pesquisa do Estado da Bahia
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • National Council for Scientific and Technological Development
  • Bahia State Research Support Foundation

Zitieren

APA

Carvalho, V. M. P., Hielm-Björkman, A., Damasceno, K. A., Fontes, T. N., Vieira-Filho, C. H. D. C., Nunes, S., Reis, D. C. D., Moore, R., Barrouin-Melo, S. M., Cassali, G. D., & Estrela-Lima, A. (2026). Prognostic Potential of the NRF2 Transcription Factor in Canine Mammary Neoplasms. Cancers, 18(7), 1107. https://doi.org/10.3390/cancers18071107

Vancouver

Carvalho VMP, Hielm-Björkman A, Damasceno KA, Fontes TN, Vieira-Filho CHDC, Nunes S, et al. Prognostic Potential of the NRF2 Transcription Factor in Canine Mammary Neoplasms. Cancers. 2026;18(7):1107. doi:10.3390/cancers18071107

BibTeX
@article{Carvalho2026,
  author = {Carvalho, Vitor de Moraes Pina de and Hielm-Björkman, Anna and Damasceno, Karine Araújo and Fontes, Thanielle Novaes and Vieira-Filho, Carlos Humberto da Costa and Nunes, Simone and Reis, Diego Carlos Dos and Moore, Robin and Barrouin-Melo, Stella Maria and Cassali, Geovanni Dantas and Estrela-Lima, Alessandra},
  title = {Prognostic Potential of the NRF2 Transcription Factor in Canine Mammary Neoplasms},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {7},
  pages = {1107},
  doi = {10.3390/cancers18071107}
}
Kostenlos starten →